Delivery Order SPE2DB22D1041-SPE2DB25FUBW9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order valued at $15,635.30 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $40,974.26 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication that represents part of the broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $9,840.04 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on August 18, 2025, with completion targeted for August 19, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used for diabetes management, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,681.38 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens on August 29, 2025, with completion expected by September 2, 2025. This competitively awarded, firm fixed-price delivery order requires fulfillment at AmerisourceBergen's Conshohocken, Pennsylvania location and represents no set-aside designation. Mounjaro is a prescription medication used for diabetes management, consistent with AmerisourceBergen's role...
- The Defense Logistics Agency awarded a $1,568.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Mounjaro 10 mg/0.5 ml pens (0.5 ml units). This is a non-set-aside, competitively awarded contract with a completion date of August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $26,741.23 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pens on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through...
- The Defense Logistics Agency awarded a delivery order valued at $19,551.08 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, reflecting the contractor's established...
- The Defense Logistics Agency awarded a $15,269.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.77 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUBW9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,470.35 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units) with a completion date of September 9, 2025. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products supplied to federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As the prime contractor under this IDC, AmerisourceBergen supplies a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company serves critical federal customers including the Defense Health Agency and U.S. Coast Guard through this flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 9/8/25 |